NCT00764270

The Role of R-Alpha Lipoic Acid in the Treatment of Atherosclerotic Vascular Disease

The Role of R-alpha Lipoic Acid in the Treatment of Atherosclerotic Vascular Disease

• Status: Completed
• Phase: Phase 2 / Phase 3
• Study type: Interventional
• Enrollment: 28 (actual)
• Sponsor: Oregon State University · Academic / Other
• Sex: All
• Age: 50 Years – 70 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to see if a dietary supplement, R-alpha lipoic acid, is able to reduce risk factors in people with documented heart disease and increased levels of inflammation.

Conditions

• Atherosclerosis

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	R-alpha lipoic acid	300 mg R-alpha lipoic acid or placebo twice daily for 12 weeks, followed by a washout period of 12 weeks, followed by another treatment phase of the other treatment placebo or 300 mg R-alpha-lipoic acid for 12 weeks

Timeline

• Start date: 2011-08-01
• Primary completion: 2011-11-01
• Completion: 2024-10-01
• First posted: 2008-10-02
• Last updated: 2025-04-11

Locations

1 site across 1 country: United States